DISCO Pharmaceuticals GmbH

[DISCO Pharmaceuticals GmbH @DISCOPharma]

Learn more about DISCO here👉 https://t.co/OCCBhAQTU3

[DISCO Pharmaceuticals GmbH @DISCOPharma]

👀 Check out @BioCentury's latest Emerging Company Profile series featuring our Roman Thomas who spoke @DanielleGolovin about our disruptive #surfaceome mapping technology.
Read the profile using the link in the comments below 👇
#Proteomics #Optoproteomics #DrugDiscovery

[DISCO Pharmaceuticals GmbH @DISCOPharma]

Amazing night at the @lifestarawards where @DISCOPharma was presented with the Seed🌱Raise of the Year award 👏.
Thank you to the 🥳 DISCO team and our investors for their support & dedication❤️!
Congrats to all the winners and finalists!
#lifestarawards

[DISCO Pharmaceuticals GmbH @DISCOPharma]

🔗 Learn more about DISCO's disruptive surfaceome mapping technology here: 👉https://t.co/leO1iT6j6e

[DISCO Pharmaceuticals GmbH @DISCOPharma]

Catch @DISCO Pharma at Cancer R&D 2024 from 18-20 Nov!
Connect🤝with Norbert Volkmar, Scientist at DISCO to learn more about how we accomplished the first-ever mapping of the #SCLC #surfaceome.
#CancerResearch

[DISCO Pharmaceuticals GmbH @DISCOPharma]

@OptimumComms 📣Listen to our CEO Roman Thomas in the #LungCancerAwarenessMonth episode of the #OptimumPerspectives Podcast as he discusses the breakthroughs in #lungcancer treatments and @DISCOPharma to develop its #surfaceome mapping platform.

@health_journo @OptimumComms

[OptimumComms @OptimumComms]

🎙️In this podcast to mark #LungCancerAwarenessMonth, Optimum’s Richard Staines speaks to Roman Thomas, CEO and founder of @DISCOPharma, on breakthroughs that have improved patient outcomes, and the company’s efforts to help develop new therapies with its “surfaceome” technology.
Listen to the full episode here: https://t.co/fQBUtnWmT2

[DISCO Pharmaceuticals GmbH @DISCOPharma]

Meet @DISCOPharma at @HansonWade 's #WorldADC in sunny☀San Diego⛱ from 4-7 Nov to learn more about we are overcoming the challenges in ADC development using our disruptive #surfaceome mapping technology.
#AntibodyDrugConjugates

[DISCO Pharmaceuticals GmbH @DISCOPharma]

Join @DISCOPharma in Dresden, 🇩🇪 for the 23rd @hupo_org World🌍Congress from 20-24 October.
💬Connect with us onsite to explore how DISCO is transforming #cancer care by expanding the molecular target🎯space with our cutting-edge #surfaceome mapping technology🦠.
#HUPO2024 #EuPA

[DISCO Pharmaceuticals GmbH @DISCOPharma]

Our Head of Technology & DISCO Zürich, Emanuela Tschudy-Milani, will be attending the @festofbiologics in Basel🗻from 15-17 Oct.
Reach out to connect with Emanuela onsite to learn more about our groundbreaking #surfaceome mapping technology.
#FestivalofBiologics2024

[DISCO Pharmaceuticals GmbH @DISCOPharma]

Read more👉https://t.co/pr2FEjiOiP

[DISCO Pharmaceuticals GmbH @DISCOPharma]

📰This just in! 📰
@DISCOPharma has been featured in @DDWJournal's latest article on the future of #ADCs !
We're proud to be recognised for our pioneering work in identifying novel druggable targets🎯using our disruptive #surfaceome mapping technology.

[DISCO Pharmaceuticals GmbH @DISCOPharma]

On #WorldLungDay, @DISCO Pharma is proud to support global lung health awareness. Using our breakthrough discovery platform, we've successfully mapped the #surfaceome of Small Cell #LungCancer cells and are developing target-specific therapies to improve patient care.

[DISCO Pharmaceuticals GmbH @DISCOPharma]

Learn more about DISCO here 👉 https://t.co/leO1iT6j6e

[DISCO Pharmaceuticals GmbH @DISCOPharma]

There’s lots of optimism as noted in @RealEndptsMel's recent article published in @Nature's Biotechnology.

Alongside other notable events, our €20m seed financing suggests the sector is headed in the right direction.

Read the full article here 👉 https://t.co/W8zSslEOJ3

[DISCO Pharmaceuticals GmbH @DISCOPharma]

Sometimes you need to retreat from the spotlight and relax.
The DISCO team sashayed its way to Karlsruhe, Germany to connect, reflect and fortify our #teambuilding skills.

[DISCO Pharmaceuticals GmbH @DISCOPharma]

On #WorldLungCancerDay, we want to raise awareness of the most aggressive form of lung cancer: #SmallCellLungCancer (#SCLC).

At @DISCOPharma, we have completed the first-ever mapping of the SCLC #surfaceome.

Learn more here👉https://t.co/leO1iT6j6e

#WLCD2024

[DISCO Pharmaceuticals GmbH @DISCOPharma]

Our CEO, Roman Thomas, spoke🎙to Janelle Hart at @Citeline , following his recognition as one of #InVivosRisingLeaders2024.
Read the article to learn about our target 🎯discovery platform technology and its potential to redefine cancer #drugdiscovery: https://t.co/KTNGuxgXTN